Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
CA 2352963 A1 · Owner: Strober, Warren · Inventors: Strober, Warren; Ludviksson, Bjorn R.; Ehrhardt, Rolf O.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method of treating inflammation comprising , administering an antagonist to .alpha.E.beta.7. The present invention further provides a method of preventing inflammation comprising administering an , antagonist to .alpha.E.beta.7. Also provided is a method of screening for a substance effective in reducing the inflammatory effects of .alpha.E.beta.7 comprising administering the substance to an animal having an established inflammatory disease; assaying inflammatory tissue cells from the animal for an amount of secretion of proinflammatory cytokines inflammatory cytokines or , chemokines whereby a decrease in the amount of proinflammatory cytokines …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.